Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission

Not Recruiting

Trial ID: NCT00186381

Age - 16 Years-69 Years Condition - Blood and Marrow Transplant (BMT), Leukemia Gender - All Accepting Healthy Volunteers - No

Evaluate the role of high dose chemotherapy with autologous hematopoietic cell transplantation for AML.

Autologous Bone Marrow Transplantation for Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission

Laura Johnston

Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)

Robert Negrin

Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)

Sally Arai

Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)

Inclusion Criteria:- must be in remission

   - adequate organ function Exclusion Criteria:- prior MDS

   - active infection

   - liver disease

procedure: high dose chemotherapy then autologous hematopoietic cell transplant

Not Recruiting

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
BMT Referrals
6507230822

Receive email alerts when trials open to patients.

Enter email address